Radium-223 in Metastatic Castration-Resistant Prostate Cancer: Clinical Development and Use in Contemporary Practice

被引：3
|
作者：
Morgan, Scott C. [1 ,2 ]
机构：
[1] Ottawa Hosp Canc Ctr, Div Radiat Oncol, 501 Smyth Rd,Box 903, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Radiol, Div Radiat Oncol, Ottawa, ON, Canada
来源：
JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES | 2019年 / 50卷 / 04期
关键词：
Alpha particles; radioisotopes; castration-resistant prostate cancer; bone metastases; INCREASED SURVIVAL; OPEN-LABEL; ENZALUTAMIDE; DICHLORIDE; THERAPY; ABIRATERONE; CARE; MEN;
D O I：
10.1016/j.jmir.2019.05.006
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Radium-223 is a first-in-class alpha particle-emitting radionuclide. Unlike the beta emitters whose development preceded it and whose use has largely been limited to symptom palliation, radium-223 has been shown to meaningfully alter the natural history of bonepredominant metastatic castration-resistant prostate cancer and improve overall survival. This review-a precis of a lecture given at the Eleventh International Symposium on Targeted Alpha Therapy in April 2019-discusses the radiobiological properties of radium-223, summarizes its clinical development over the past decade, and situates it in the current therapeutic landscape for metastatic castration-resistant prostate cancer.
引用
收藏
页码：S26 / S30
页数：5
相关论文
共 50 条
  • [21] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Pleskow, H.
    Otani, K.
    Kusaka, E.
    Ukleja, J.
    Balza, R.
    Fisher, R.
    Broderick, K.
    Maheswaran, S.
    Haber, D.
    Saylor, P. J.
    Miyamoto, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
  • [22] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    UROLOGY, 2015, 85 (04) : 717 - 724
  • [23] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
  • [24] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel
    Daria Handkiewicz-Junak
    Michael Andreeff
    Alexander Becherer
    Andreas Bockisch
    Eva Fricke
    Lilli Geworski
    Alexander Heinzel
    Bernd J. Krause
    Thomas Krause
    Markus Mitterhauser
    Wilfried Sonnenschein
    Lisa Bodei
    Roberto C. Delgado-Bolton
    Michael Gabriel
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 824 - 845
  • [25] Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Saylor, Philip J.
    Otani, Keisuke
    Balza, Rene
    Ukleja, Jacob
    Pleskow, Haley
    Fisher, Rebecca
    Kusaka, Erika
    Otani, Yukako S.
    Badusi, Priscilla Oluwakemi
    Smith, Matthew R.
    Meneely, Erika
    Olivier, Kara
    Lowe, Alarice C.
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    Yeap, Beow Y.
    Lee, Richard J.
    Miyamoto, David T.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [26] Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223
    Rodriguez-Vida, A.
    Torregrosa, M. D.
    Pinto, A.
    Climent, M. A.
    Olmos, D.
    Carles, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 679 - 686
  • [27] A Case of Success: Complete Response to Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Pinho, Ines Soares de
    Esperanca-Martins, Miguel
    Machado, Barbara
    Damaso, Sara
    Bras, Raquel Lopes
    Cantinho, Guilhermina
    Fernandes, Isabel
    Costa, Luis
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [28] EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Poeppel, Thorsten D.
    Handkiewicz-Junak, Daria
    Andreeff, Michael
    Becherer, Alexander
    Bockisch, Andreas
    Fricke, Eva
    Geworski, Lilli
    Heinzel, Alexander
    Krause, Bernd J.
    Krause, Thomas
    Mitterhauser, Markus
    Sonnenschein, Wilfried
    Bodei, Lisa
    Delgado-Bolton, Roberto C.
    Gabriel, Michael
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 824 - 845
  • [29] Predictors for Survival After Radium-223 Treatment for Castration-Resistant Metastatic Prostate Cancer
    Anderson, E.
    Wong, W. W.
    Mohammadi, H.
    Daniels, T. B.
    Vora, S.
    Schild, S. E.
    Keole, S. R.
    Choo, C. R.
    Tzou, K. S.
    Bryce, A.
    Ho, T. H.
    Quevedo, F. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E255 - E255
  • [30] Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale
    Sedhom, Ramy
    Antonarakis, Emmanuel S.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S341 - S345
12345